Dr. Amaria on Genetically Modified TILs in Melanoma

Adoptive Cell Therapy Using TIL for Metastatic MelanomaПодробнее

TIL ( Tumor Infiltrating Immunotherapy) TREATMENTПодробнее

The future of OBX-115, a novel TIL, in the melanoma treatment landscapeПодробнее

Genetic testing in familial melanomaПодробнее

Understanding TIL (Tumour-infiltrating lymphocyte) TherapyПодробнее

Uveal Melanoma: TIL - Presentation Recording - Dr. ButlerПодробнее

TIL and Adoptive Therapy - Mark B Faries MDПодробнее

Meet melanoma medical oncologist Rodabe Amaria, M.D.Подробнее

Focusing on You: Localized Immunotherapy Treatment for MelanomaПодробнее

The Genetics of Melanoma: Searching for New Therapeutic Targets - Yardena SamuelsПодробнее

Tumour-infiltrating lymphocyte treatment for advanced melanomaПодробнее

Cell Therapy in the Treatment of Solid TumorsПодробнее

Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John BridgemanПодробнее

TIL Cell Therapy in MelanomaПодробнее

The impact of metastasectomy in patients with melanoma receiving TILsПодробнее

TIL 3.0 culture method for primary and metastatic uveal melanomaПодробнее

Dr. Fischkoff on Vision for TIL Therapy in MelanomaПодробнее

Melanoma dedifferentiation as an escape mechanism for immunotherapy and ACTПодробнее

Immunotherapy: T-Cell Adoptive Therapy - Dr. Faries Melanoma Education Symposium 2014Подробнее